Page last updated: 2024-08-26

fulvestrant and Cardiovascular Stroke

fulvestrant has been researched along with Cardiovascular Stroke in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booth, EA; Kilbourne, EJ; Lucchesi, BR; Marchesi, M1
Aronovitz, MJ; Baur, J; Celestin, F; Chen, X; Force, T; Grohe, C; Haq, S; Karas, RH; Mendelsohn, ME; Michael, A; Nuedling, S; Patten, RD; Pourati, I1
Booth, EA; Kilbourne, EJ; Knittel, AK; Lucchesi, BR; Marchesi, M1
Chou, TF; Lee, TM; Su, SF; Tsai, CH1

Other Studies

4 other study(ies) available for fulvestrant and Cardiovascular Stroke

ArticleYear
17Beta-estradiol as a receptor-mediated cardioprotective agent.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:1

    Topics: Animals; Cardiotonic Agents; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Hemodynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Rabbits; Receptors, Estrogen; Reperfusion Injury

2003
17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling.
    Circulation research, 2004, Oct-01, Volume: 95, Issue:7

    Topics: Amino Acid Chloromethyl Ketones; Androstadienes; Animals; Apoptosis; Cells, Cultured; Chromones; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Myocardial Infarction; Myocytes, Cardiac; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Recombinant Fusion Proteins; Signal Transduction; Wortmannin

2004
The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:6

    Topics: Animals; Disease Models, Animal; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Ligands; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Ovariectomy; Pyrazoles; Rabbits; Receptors, Estrogen; Selective Estrogen Receptor Modulators

2007
Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:1

    Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Benzamides; Blood Pressure; Decanoic Acids; Dogs; Electrocardiography; Estradiol; Estrogen Antagonists; Fulvestrant; Hydroxy Acids; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Potassium Channels; Sarcolemma; Ventricular Function, Left

2002